This is a Validated Antibody Database (VAD) review about dog DLA-DRA, based on 152 published articles (read how Labome selects the articles), using DLA-DRA antibody in all methods. It is aimed to help Labome visitors find the most suited DLA-DRA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
DLA-DRA synonym: DLA-DRA1; MHC class II DR alpha chain

BioLegend
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig 2b
BioLegend DLA-DRA antibody (Biolegend, 307602) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 2 ug/ml; loading ...; fig s13
BioLegend DLA-DRA antibody (BioLegend, 307623) was used in flow cytometry on human samples at 2 ug/ml (fig s13). Science (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3a
BioLegend DLA-DRA antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:200; loading ...; fig 1b
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:200 (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s3k
BioLegend DLA-DRA antibody (Biolegend, 307618) was used in flow cytometry on human samples (fig s3k). Cell Rep (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 4a
BioLegend DLA-DRA antibody (BioLegend, 307618) was used in flow cytometry on human samples (fig 4a). J Exp Med (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1c
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1c). J Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend DLA-DRA antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s2d
BioLegend DLA-DRA antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s3b
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3b). J Exp Med (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend DLA-DRA antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend DLA-DRA antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). Nucleic Acids Res (2018) ncbi
mouse monoclonal (L243)
  • blocking or activating experiments; human; loading ...; fig s2b
BioLegend DLA-DRA antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig s2b). Nat Med (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 4a
BioLegend DLA-DRA antibody (BioLegend, H243) was used in flow cytometry on human samples (fig 4a). Int J Infect Dis (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1b
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1b). JCI Insight (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3b
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3b). Oncol Lett (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 1a
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). J Exp Med (2018) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend DLA-DRA antibody (BioLegend, L243) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:50; loading ...
In order to define the transcriptional network specifies conferring microglia identity, BioLegend DLA-DRA antibody (BioLegend, 307616) was used in flow cytometry on human samples at 1:50. Science (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl s3
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend DLA-DRA antibody (biolegend, L243) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig 1h
  • flow cytometry; human
In order to map the lineage of human dendritic cells, BioLegend DLA-DRA antibody (Biolegend, L243) was used in mass cytometry on human samples (fig 1h) and in flow cytometry on human samples . Science (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s6a
In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). MBio (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2e
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2e). Oncoimmunology (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:200; loading ...; fig s1d
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples at 1:200 (fig s1d). Nat Commun (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2b
In order to analyze B-cell responses to meningococcal polysaccharide and conjugate vaccines against Neisseria meningitidis, BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). Genome Med (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; mouse; loading ...; fig 2d
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; Rhesus monkey; loading ...; fig 7a
In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on Rhesus monkey samples (fig 7a). J Virol (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3b
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2a
BioLegend DLA-DRA antibody (BioLegend, 307606) was used in flow cytometry on human samples (fig 2a). Oncogene (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; mouse; loading ...; fig 1c
In order to test if Mincle signaling drives intrahepatic inflammation and liver injury in Con A hepatitis, BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl 2
In order to identify peanut proteins that can predict peanut allergy., BioLegend DLA-DRA antibody (Biolegend, 307624) was used in flow cytometry on human samples (tbl 2). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2b
In order to elucidate the mechanisms by which DRibbles induce T-cell activation, BioLegend DLA-DRA antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 2b). Cell Death Dis (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 6a
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2b
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). PLoS ONE (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 7a
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 7a). J Biol Chem (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s3
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi
mouse monoclonal (Tu39)
  • flow cytometry; human; loading ...; tbl 1
BioLegend DLA-DRA antibody (BioLegend, Tu39) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Am J Transplant (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig s1c
  • immunocytochemistry; human
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1c) and in immunocytochemistry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:200; loading ...; fig s1a
In order to find that central nervous system infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic amyotrophic lateral sclerosis mouse model, BioLegend DLA-DRA antibody (Biolegend, 307616) was used in flow cytometry on human samples at 1:200 (fig s1a). Acta Neuropathol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig s6a
In order to test if AML patients treated decitabine have induced expression of cancer testis antigens, BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). Oncotarget (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:20; fig 2
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:20 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (L243)
  • other; human; loading ...; fig st1
  • flow cytometry; human; loading ...; fig st3
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BioLegend DLA-DRA antibody (BioLegend, L243) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BioLegend DLA-DRA antibody (BioLegend, 307610) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1b
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 1
BioLegend DLA-DRA antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend DLA-DRA antibody (Biolegend, 307604) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 2a
In order to investigate the effect of thymosin on HL-60 cell maturation, BioLegend DLA-DRA antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (Tu39)
  • flow cytometry; human
BioLegend DLA-DRA antibody (Biolegend, #361703) was used in flow cytometry on human samples . Am J Transplant (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; tbl s1
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 9a
In order to explore a macrophage TLR9-BTK-calcineurin-NFAT signaling pathway involved in impair fungal immunity, BioLegend DLA-DRA antibody (Biolegend, 307617) was used in flow cytometry on human samples (fig 9a). EMBO Mol Med (2015) ncbi
mouse monoclonal (L243)
  • blocking or activating experiments; human; 15 ug/ml; fig 4
BioLegend DLA-DRA antibody (BioLegend, L432) was used in blocking or activating experiments on human samples at 15 ug/ml (fig 4). Vaccine (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend DLA-DRA antibody (BioLegend, clone L243) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 3
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Nephrol Dial Transplant (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend DLA-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 1
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend DLA-DRA antibody (Biolegend, 307604) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 6b
BioLegend DLA-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 6b). J Immunol (2014) ncbi
mouse monoclonal (L243)
In order to investigate the progression of innate responses to mycobacteria in infants, BioLegend DLA-DRA antibody (Biolegend, L243) was used . J Immunol (2014) ncbi
mouse monoclonal (L243)
  • blocking or activating experiments; human; loading ...; fig 5A
In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, BioLegend DLA-DRA antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig 5A). J Immunol (2014) ncbi
Invitrogen
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3c
Invitrogen DLA-DRA antibody (eBioscience, 11-9952-41) was used in flow cytometry on human samples (fig 3c). Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen DLA-DRA antibody (eBioscience, L243) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; Rhesus monkey; loading ...; fig 1a
In order to examine frequency and function of myeloid-derived suppressor cells in SIV-infected rhesus macaques, Invitrogen DLA-DRA antibody (Fisher Scientific, L243) was used in flow cytometry on Rhesus monkey samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
In order to study the restoration of immune function in chronic HIV infection, Invitrogen DLA-DRA antibody (eBioscience, L240) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, Invitrogen DLA-DRA antibody (eBioscience, L243) was used in flow cytometry on human samples . Int J Cancer (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:50; fig s2c
In order to develop and characterize a humanized ossicle xenotransplantation approach, Invitrogen DLA-DRA antibody (ebioscience, L243) was used in flow cytometry on human samples at 1:50 (fig s2c). Nat Med (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:20; loading ...; fig s5j
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen DLA-DRA antibody (eBioscience, 12-9952-41) was used in flow cytometry on human samples at 1:20 (fig s5j). Nat Cell Biol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig st1
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, Invitrogen DLA-DRA antibody (eBiosciences, L243-ef450) was used in flow cytometry on human samples (fig st1). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
Invitrogen DLA-DRA antibody (eBioscience, 25-9952-41) was used in flow cytometry on human samples . Nanomedicine (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
Invitrogen DLA-DRA antibody (eBioscience, L243) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen DLA-DRA antibody (eBioscience, 48-9952-42) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
BD Biosciences
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1d
BD Biosciences DLA-DRA antibody (BD PharMingen, 560943) was used in flow cytometry on human samples (fig 1d). J Exp Med (2018) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 5c). J Immunol (2017) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; 1:500; loading ...; fig s1b
In order to study the antigen presentation by HLA-DP84Gly through the class I antigen processing pathway, BD Biosciences DLA-DRA antibody (BD Biosciences, 555561) was used in flow cytometry on human samples at 1:500 (fig s1b). Nat Commun (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...
In order to test if TRAIL/TRAIL-R signaling in cancer cells alters the immune microenvironment, BD Biosciences DLA-DRA antibody (BD Bioscience, 556643) was used in flow cytometry on human samples . Mol Cell (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 6e
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences DLA-DRA antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 6e). Sci Rep (2017) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 4b
BD Biosciences DLA-DRA antibody (BD Biosciences, 555560) was used in flow cytometry on human samples (fig 4b). PLoS ONE (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; tbl 3
In order to optimize a method to generate granulocyte lineage-committed progenitors from umbilical cord blood samples, BD Biosciences DLA-DRA antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (tbl 3). N Biotechnol (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
In order to evaluate combinations of TLR and C-type lectin receptor agonists on the Th1 responses of newborn dendritic cells, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences DLA-DRA antibody (BD Biosciences, 560944) was used in flow cytometry on human samples (fig 1c). Mol Med Rep (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; Rhesus monkey; loading ...; fig s11b
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BD Biosciences DLA-DRA antibody (BD Pharmingen, 552764) was used in flow cytometry on Rhesus monkey samples (fig s11b). Science (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BD Biosciences DLA-DRA antibody (BD, 560896) was used in flow cytometry on human samples (fig 4a). J Virol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 4b
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 4b). Oncotarget (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
In order to investigate the impact of CD1c positive dendritic cells on immunogenic cell death, BD Biosciences DLA-DRA antibody (BD PharMingen, 555812) was used in flow cytometry on human samples . Oncoimmunology (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:1000
BD Biosciences DLA-DRA antibody (BD Biosciences, 560896) was used in flow cytometry on human samples at 1:1000. Oncol Lett (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1
BD Biosciences DLA-DRA antibody (BD Biosciences, 555812) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1
BD Biosciences DLA-DRA antibody (BD Biosciences, 556644) was used in flow cytometry on human samples (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 1). J Transl Med (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 2
In order to assess the ability of human cystatin C to alter pathogenic activated monocytes and modulate Crohn's disease, BD Biosciences DLA-DRA antibody (BD Pharmingen, TU36) was used in flow cytometry on human samples (fig 2). J Leukoc Biol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:200; loading ...; fig 7j
In order to find that coagulation factor XII modulates immune responses, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples at 1:200 (fig 7j). Nat Commun (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 7a
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 7a). PLoS ONE (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the protective immunological events induced by vaccination with Leishmune in dogs, BD Biosciences DLA-DRA antibody (BD Biosciences, 559866) was used in flow cytometry on human samples (tbl 2). Vet Parasitol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1
BD Biosciences DLA-DRA antibody (BD Biosciences, 555811) was used in flow cytometry on human samples (fig 1). Int J Mol Med (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences DLA-DRA antibody (BD, 555561) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 7c
BD Biosciences DLA-DRA antibody (BD Bioscience, TU36) was used in flow cytometry on human samples (fig 7c). PLoS ONE (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:40; fig 2
BD Biosciences DLA-DRA antibody (BD Horizon, G46-6) was used in flow cytometry on human samples at 1:40 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 5
BD Biosciences DLA-DRA antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig S1A
In order to analyze the frequency and phenotype of monocyte subpopulations in peripheral blood, cerebrospinal fluid, and brain biopsy material derived from multiple sclerosis patients, BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig S1A). J Immunol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences DLA-DRA antibody (BD Pharmingen, 560943) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences DLA-DRA antibody (BD Biosciences, TU36) was used in flow cytometry on human samples (fig 1c). Cytotherapy (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig s3). Sci Transl Med (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; Rhesus monkey
In order to characterize functional and phenotypic properties of monoclonal antibodies specific for Rhesus Macaque CD200, Mincle, and CD200R, BD Biosciences DLA-DRA antibody (BD, 552764) was used in flow cytometry on Rhesus monkey samples . PLoS ONE (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 2i
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2i). J Immunol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; mouse; loading ...; fig s2d
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on mouse samples (fig s2d). Nat Chem Biol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; cat; 1:50; tbl 3
BD Biosciences DLA-DRA antibody (BD Biosciences,, 555810) was used in flow cytometry on cat samples at 1:50 (tbl 3). Cell Reprogram (2015) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; tbl 1
BD Biosciences DLA-DRA antibody (BD bioscience, 555561) was used in flow cytometry on human samples (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 2
BD Biosciences DLA-DRA antibody (BD Biosciences, 555810) was used in flow cytometry on human samples (fig 2). Int J Mol Med (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
In order to generate three different polarized macrophage and assess their immune function in an air-blood barrier co-culture, BD Biosciences DLA-DRA antibody (BD Biosciences, 559866) was used in flow cytometry on human samples . J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to discuss the contribution of missense mutations in PDE3A to hypertension, BD Biosciences DLA-DRA antibody (BD Biosciences, 555561) was used in flow cytometry on human samples . Nat Genet (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 2
  • immunocytochemistry; human; fig 1
BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples (fig 2) and in immunocytochemistry on human samples (fig 1). Immunol Cell Biol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 3
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig 3). J Exp Med (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 2
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Pharmingen, 559866) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; tbl 1
BD Biosciences DLA-DRA antibody (BD Biosciences, 555812) was used in flow cytometry on human samples (tbl 1). Exp Ther Med (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:5
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples at 1:5. Nat Commun (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 2
BD Biosciences DLA-DRA antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (fig 2). Blood (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 4
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 4). Immunol Cell Biol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (G46-6)
  • immunohistochemistry - paraffin section; human; 1:100
BD Biosciences DLA-DRA antibody (BD Biosciences, 555811) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mol Med Rep (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples . PLoS Negl Trop Dis (2014) ncbi
mouse monoclonal (TU36)
  • immunocytochemistry; mouse
BD Biosciences DLA-DRA antibody (PharMingen, TU36) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (Becton Dickenson, G46-6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Clin Exp Allergy (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (G46-6)
  • immunoprecipitation; human
  • western blot; human
In order to demonstrate that CPXV012 inhibits peptide transport by inhibiting ATP binding to the transporter associated with antigen processing, BD Biosciences DLA-DRA antibody (BD Pharmingen, 347401) was used in immunoprecipitation on human samples and in western blot on human samples . J Immunol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences DLA-DRA antibody (BD Biosciences, 555812) was used in flow cytometry on human samples (fig s1b). Oncotarget (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
In order to investigate the effects of Nucleofection on freshly isolated primary CD4 T cell morphology, intracellular calcium levels, cell surface activation markers, and transcriptional activity, BD Biosciences DLA-DRA antibody (Becton Dickinson Pharmingen, 555811) was used in flow cytometry on human samples . J Immunol Methods (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6/L243) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Mol Immunol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 4B
In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig 4B). J Immunol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:5
BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples at 1:5. Microvasc Res (2012) ncbi
Articles Reviewed
  1. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  2. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  3. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  4. Georgouli M, Herraiz C, Crosas Molist E, Fanshawe B, Maiques O, Perdrix A, et al. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. Cell. 2019;176:757-774.e23 pubmed publisher
  5. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  6. Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed publisher
  7. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  8. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed publisher
  9. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  10. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  11. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  12. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  13. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  14. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  15. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  16. Dumbovic G, Biayna J, Banús J, Samuelsson J, Roth A, Diederichs S, et al. A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer. Nucleic Acids Res. 2018;46:5504-5524 pubmed publisher
  17. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  18. Mitchell K, Barreyro L, Todorova T, Taylor S, Antony Debré I, Narayanagari S, et al. IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med. 2018;215:1709-1727 pubmed publisher
  19. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
  20. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  21. Liu R, Merola J, Manes T, Qin L, Tietjen G, Lopez Giraldez F, et al. Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. JCI Insight. 2018;3: pubmed publisher
  22. Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines. Oncol Lett. 2018;15:509-514 pubmed publisher
  23. Bujko A, Atlasy N, Landsverk O, Richter L, Yaqub S, Horneland R, et al. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J Exp Med. 2018;215:441-458 pubmed publisher
  24. Resheq Y, Menzner A, Bosch J, Tickle J, Li K, Wilhelm A, et al. Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13. J Immunol. 2017;199:1672-1681 pubmed publisher
  25. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  26. Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed publisher
  27. Yamashita Y, Anczurowski M, Nakatsugawa M, Tanaka M, Kagoya Y, Sinha A, et al. HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway. Nat Commun. 2017;8:15244 pubmed publisher
  28. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed publisher
  29. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  30. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed publisher
  31. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  32. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  33. Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A, et al. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2. Mol Cell. 2017;65:730-742.e5 pubmed publisher
  34. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  35. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
  36. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed publisher
  37. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  38. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed publisher
  39. Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, et al. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS ONE. 2016;11:e0168276 pubmed publisher
  40. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  41. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  42. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
  43. Faivre V, Lukaszewicz A, Payen D. Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells. PLoS ONE. 2016;11:e0164489 pubmed publisher
  44. Casamayor Genescà A, Pla A, Oliver Vila I, Pujals Fonts N, Marín Gallén S, Caminal M, et al. Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells. N Biotechnol. 2017;35:19-29 pubmed publisher
  45. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  46. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  47. Yu Z, Zou Y, Fan J, Li C, Ma L. Notch1 is associated with the differentiation of human bone marrow?derived mesenchymal stem cells to cardiomyocytes. Mol Med Rep. 2016;14:5065-5071 pubmed publisher
  48. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed publisher
  49. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  50. Misra S, Selvam A, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, et al. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. 2016;7:74686-74700 pubmed publisher
  51. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  52. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  53. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  54. Di Blasio S, Wortel I, van Bladel D, de Vries L, Duiveman de Boer T, Worah K, et al. Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death. Oncoimmunology. 2016;5:e1192739 pubmed publisher
  55. Zahran A, Aly S, Altayeb H, Ali A. Circulating endothelial cells and their progenitors in acute myeloid leukemia. Oncol Lett. 2016;12:1965-1970 pubmed
  56. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  57. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed publisher
  58. Greco S, Torres Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, et al. Mincle Signaling Promotes Con A Hepatitis. J Immunol. 2016;197:2816-27 pubmed publisher
  59. van Erp F, Knol E, Pontoppidan B, Meijer Y, van der Ent C, Knulst A. The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children. J Allergy Clin Immunol. 2017;139:358-360.e8 pubmed publisher
  60. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed publisher
  61. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
  62. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  63. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed publisher
  64. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed publisher
  65. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  66. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  67. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  68. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed publisher
  69. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  70. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  71. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  72. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  73. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
  74. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  75. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  76. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  77. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher
  78. Chung S, Rho S, Kim G, Kim S, Baek K, Kang M, et al. Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury. Int J Mol Med. 2016;37:1170-80 pubmed publisher
  79. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  80. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  81. Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed publisher
  82. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Blagitko Dorfs N, et al. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget. 2016;7:12840-56 pubmed publisher
  83. Gupta S, Termini J, Issac B, Guirado E, Stone G. Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors. PLoS ONE. 2016;11:e0148929 pubmed publisher
  84. Johnson D, Estrada M, Salgado R, Sanchez V, Doxie D, Opalenik S, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016;7:10582 pubmed publisher
  85. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  86. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  87. Waschbisch A, Schröder S, Schraudner D, Sammet L, Weksler B, Melms A, et al. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System. J Immunol. 2016;196:1558-67 pubmed publisher
  88. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  89. Wang H, Feng F, Wang X, Wang R, Wu Y, Zhu M, et al. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma. Mol Med Rep. 2016;13:1077-82 pubmed publisher
  90. Oliver Vila I, Coca M, Grau Vorster M, Pujals Fonts N, Caminal M, Casamayor Genescà A, et al. Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly. Cytotherapy. 2016;18:25-35 pubmed publisher
  91. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  92. Byrareddy S, Little D, Mayne A, Villinger F, Ansari A. Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle. PLoS ONE. 2015;10:e0140689 pubmed publisher
  93. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  94. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  95. McCausland M, Juchnowski S, Zidar D, Kuritzkes D, Andrade A, Sieg S, et al. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 2015;10:e0139474 pubmed publisher
  96. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed publisher
  97. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  98. Gómez M, Qin Q, Biancardi M, Galiguis J, Dumas C, MacLean R, et al. Characterization and Multilineage Differentiation of Domestic and Black-Footed Cat Mesenchymal Stromal/Stem Cells from Abdominal and Subcutaneous Adipose Tissue. Cell Reprogram. 2015;17:376-92 pubmed publisher
  99. Monteiro Carvalho Mori da Cunha M, Zia S, Oliveira Arcolino F, Carlon M, Beckmann D, Pippi N, et al. Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats. PLoS ONE. 2015;10:e0136145 pubmed publisher
  100. Li X, Liu X, Zhao Y, Zhong R, Song A, Sun L. Effect of thymosin α₁ on the phenotypic and functional maturation of dendritic cells from children with acute lymphoblastic leukemia. Mol Med Rep. 2015;12:6093-7 pubmed publisher
  101. Bian Y, Qian W, Li H, Zhao R, Shan W, Weng X. Pathogenesis of glucocorticoid-induced avascular necrosis: A microarray analysis of gene expression in vitro. Int J Mol Med. 2015;36:678-84 pubmed publisher
  102. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  103. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  104. Kasper J, Hermanns M, Unger R, Kirkpatrick C. A responsive human triple-culture model of the air-blood barrier: incorporation of different macrophage phenotypes. J Tissue Eng Regen Med. 2017;11:1285-1297 pubmed publisher
  105. Maass P, Aydin A, Luft F, Schächterle C, Weise A, Stricker S, et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat Genet. 2015;47:647-53 pubmed publisher
  106. Thomas K, Valenzuela N, Gjertson D, Mulder A, Fishbein M, Parry G, et al. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. Am J Transplant. 2015;15:2037-49 pubmed publisher
  107. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed publisher
  108. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  109. Skogberg G, Lundberg V, Berglund M, Gudmundsdottir J, Telemo E, Lindgren S, et al. Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens. Immunol Cell Biol. 2015;93:727-34 pubmed publisher
  110. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  111. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed publisher
  112. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  113. Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240-58 pubmed publisher
  114. Tomimaru Y, Mishra S, Safran H, Charpentier K, Martin W, De Groot A, et al. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Vaccine. 2015;33:1256-66 pubmed publisher
  115. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed publisher
  116. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  117. Fytianos K, Rodríguez Lorenzo L, Clift M, Blank F, Vanhecke D, von Garnier C, et al. Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine. 2015;11:633-44 pubmed publisher
  118. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  119. Wang H, Zhang L, Zhang S, Li Y. Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells. Exp Ther Med. 2015;9:120-124 pubmed
  120. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  121. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed publisher
  122. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed publisher
  123. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. CD1c+ blood dendritic cells have Langerhans cell potential. Blood. 2015;125:470-3 pubmed publisher
  124. Fernandez C, Amarasena T, Kelleher A, Rossjohn J, McCluskey J, Godfrey D, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177-88 pubmed publisher
  125. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
  126. Liao S, Ding T, Rao X, Sun D, Sun P, Wang Y, et al. Cigarette smoke affects dendritic cell maturation in the small airways of patients with chronic obstructive pulmonary disease. Mol Med Rep. 2015;11:219-25 pubmed publisher
  127. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  128. Rogacev K, Zawada A, Hundsdorfer J, Achenbach M, Held G, Fliser D, et al. Immunosuppression and monocyte subsets. Nephrol Dial Transplant. 2015;30:143-53 pubmed publisher
  129. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  130. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed publisher
  131. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  132. Pritchard A, White O, Burel J, Carroll M, Phipps S, Upham J. Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS ONE. 2014;9:e106501 pubmed publisher
  133. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
  134. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed publisher
  135. Agrawal R, Wisniewski J, Yu M, Kennedy J, Platts Mills T, Heymann P, et al. Infection with human rhinovirus 16 promotes enhanced IgE responsiveness in basophils of atopic asthmatics. Clin Exp Allergy. 2014;44:1266-73 pubmed publisher
  136. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed publisher
  137. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  138. Luteijn R, Hoelen H, Kruse E, van Leeuwen W, Grootens J, Horst D, et al. Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP. J Immunol. 2014;193:1578-89 pubmed publisher
  139. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  140. Zhang M, Ma Z, Selliah N, Weiss G, Genin A, Finkel T, et al. The impact of Nucleofection® on the activation state of primary human CD4 T cells. J Immunol Methods. 2014;408:123-31 pubmed publisher
  141. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  142. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  143. Klinker M, Lizzio V, Reed T, Fox D, Lundy S. Human B Cell-Derived Lymphoblastoid Cell Lines Constitutively Produce Fas Ligand and Secrete MHCII(+)FasL(+) Killer Exosomes. Front Immunol. 2014;5:144 pubmed publisher
  144. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed publisher
  145. Fredriksson K, Mishra A, Lam J, Mushaben E, Cuento R, Meyer K, et al. The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses. J Immunol. 2014;192:4497-509 pubmed publisher
  146. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed publisher
  147. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher
  148. Søndergaard J, Vinner L, Brix S. Natural mannosylation of HIV-1 gp120 imposes no immunoregulatory effects in primary human plasmacytoid dendritic cells. Mol Immunol. 2014;59:180-7 pubmed publisher
  149. Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014;192:940-7 pubmed publisher
  150. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher
  151. Sölder E, Böckle B, Nguyen V, Fürhapter C, Obexer P, Erdel M, et al. Isolation and characterization of CD133+CD34+VEGFR-2+CD45- fetal endothelial cells from human term placenta. Microvasc Res. 2012;84:65-73 pubmed publisher
  152. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher